Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Notice: Revisions to the Administrative Guidance Document June 28, 2019 Our file number: 19-111818-14 Health Canada revised the Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs . This document provides information…

Notice to Stakeholders: Expiration Dating for Medical Gases On this page General requirements Rationale Stratification of Medical Gas Mixtures Compliance and Enforcement Contact Information Health Canada is issuing this notice to communicate the Department's interim approach on…

Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Overview Overview Reporting categories Pre-submission enquiries Documentation Glossary Download the alternative format (PDF format, 1.3 MB, 17 pages) Organization: Health Canada Published:…

Post-Notice of Compliance changes: Framework document for veterinary drugs On this page Foreword About post-NOC changes Classification of changes Drug submission filing information Foreword This page sets out the framework for post-Notice of Compliance (NOC) changes for…

Notice: Revised guidance documents on Post-Notice of Compliance changes for veterinary drugs Health Canada is releasing 3 associated revised guidance documents on Post-Notice of Compliance (NOC) changes for veterinary drugs. Note that documents related to drugs for human use are…

Consultation on Post-Notice of Compliance changes: Draft guidance for quality of veterinary drugs From Health Canada Current status: Closed This consultation ran from July 28, 2022 to September 26, 2022. Health Canada is seeking feedback on a proposed draft guidance document for…

Health Canada’s position on the CADTH Guidance for Reporting RWE to Support Decision-making Canada’s Drug and Health Technology Agency (CADTH) collaborated with Health Canada and other stakeholders to develop the Guidance for Reporting RWE to Support Decision-making . This…

Closed consultation: Proposal to amend the list of maximum residue limits for veterinary drugs in foods - Proposed MRL 2023-1 Current status: Closed This consultation ran from July 11, 2023 to September 24, 2023. Health Canada sought comments on a proposal to amend the List of…

Post-Notice of Compliance (NOC) Changes: Guidance for quality of veterinary drugs: Overview Overview Classification – reporting categories Documentation Examples (drug substance) Examples (drug product) Appendices Download the entire report (PDF format, 1.41 MB, 67 pages)…

Classifying pheromone-based products for companion animals: Notice to stakeholders Effective date: November 3, 2023 Some pheromone-based products are used for cats and dogs to reduce stress or calm them. This notice clarifies the classification of these types of pheromone-based…

Page 4263 of 6399Showing 42621-42630 of 63986

Early release: coverage and features are still expanding.